Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-20

FDA Approved: CARBAMAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves ANI Pharmaceuticals' original application to market a generic carbamazepine formulation under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

ORIG AP for CARBAMAZEPINE (CARBAMAZEPINE)